(Reuters) - The California-based medical device company told the U.S. Securities and Exchange Commission in a preliminary prospectus that Bear Stearns & Co. Inc., CIBC World Markets, Thomas Weisel Partners LLC and A.G. Edwards were underwriting the IPO.
Devax is a development stage medical device company with a limited history of operations and it currently does not have any products available for sale or other sources of revenue.
Read more at Reuters.com Government Filings News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment